Krystal Biotech, Inc. KRYS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $55.93M+8.8% | $51.4M-35.2% | $79.37M+107% | $38.33M+7.3% | $35.73M-21.4% | ||
| $1.52M-2.6% | $1.56M+11.6% | $1.4M+7.7% | $1.3M-7.8% | $1.41M+3.4% | ||
| $13.61M-1.1% | $13.76M+4.6% | $13.15M-6.8% | $14.12M+4.8% | $13.48M+0.9% | ||
| $80.38M+3.7% | $77.51M+95.4% | $39.66M-24.8% | $52.73M+70.3% | $30.97M-41.4% | ||
| $7.15M+234% | $2.14M+25.5% | $1.7M-10.5% | $1.9M-69.3% | $6.2M+675% | ||
| -$63.58M— | —— | -$4.29M+59.3% | -$10.53M+80.8% | -$54.77M+34.6% | ||
| -$10.46M-167% | $15.67M— | —— | —— | -$12.47M-613% | ||
| $5.01M-95.2% | $103.7M+167% | $38.78M-13.9% | $45.06M+225% | -$36.1M-24.0% | ||
| $73.23M-2.8% | $75.37M+98.6% | $37.96M-25.3% | $50.83M+105% | $24.77M-52.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Krystal Biotech, Inc. generate?
- Krystal Biotech, Inc. (KRYS) generated $250.3M in operating cash flow over the trailing twelve months.
- What is Krystal Biotech, Inc.'s free cash flow?
- After $12.9M of capital expenditures, Krystal Biotech, Inc.'s free cash flow was $237.4M over the trailing twelve months, up 76.3% year over year.
- Where does Krystal Biotech, Inc.'s cash flow data come from?
- Every line is extracted from Krystal Biotech, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
